The new Medicare program covering GLP-1 weight-loss medications, Wegovy and Zepbound, has sparked significant interest and confusion among seniors
At the Endocrine Societys 2025 meeting, researchers reported that after about 10% weight loss on a GLP-1 drug, the share of men with normal total and free testosterone rose from 53% to 77%, with no hormone therapy given
The molecule does not activate a novel pathway its distinctiveness lies in greater bioavailability, not in different signaling
the case for making the diagnosis during the first week of life
Contact us today for more information or schedule your appointment online
These ingredients may not work as rapidly or powerfully as prescription drugs, but they can play a role in weight management when used in conjunction with healthy lifestyle choices